Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Activin A activation Drives Renal Fibrosis through the STAT3 Signalling Pathway
View through CrossRef
Abstract
Background: The present study investigated whether TGF-β1 promotes fibrotic changes in HK-2 cells through the Activin A and STAT3 signalling pathways in vitro. Methods: Bioinformatics analysis of microarray profiles (GSE20247 and GSE23338) and a protein-protein interaction (PPI) analysis were performed to select hub genes. For the in vitro study, HK-2 cells were exposed to TGF-β1. The expression of Activin A and STAT3 was assayed, and the effect of Activin A and STAT3 expression on fibrosis was assessed (Collagen I and Fibronectin). Results: The bioinformatics study revealed TGF-β1 and Activin A as hub genes. The in vitro study showed that Activin A expression was significantly increased after TGF-β1 incubation. Blocking Activin A by follistatin attenuated TGF-β1-induced fibrosis. In addition, Activin A blockade attenuated TGF-β1-induced STAT3 signalling pathway activation and related fibrosis. More importantly, STAT3 inhibition by S3I-201 alleviated TGF-β1-induced fibrosis.Conclusion: Activin A promoted cellular fibrotic changes through the STAT3 signalling pathway. Attenuating Activin A expression to mediate the STAT3 signalling pathway might be a strategy for potent renal fibrosis treatment.
Title: Activin A activation Drives Renal Fibrosis through the STAT3 Signalling Pathway
Description:
Abstract
Background: The present study investigated whether TGF-β1 promotes fibrotic changes in HK-2 cells through the Activin A and STAT3 signalling pathways in vitro.
Methods: Bioinformatics analysis of microarray profiles (GSE20247 and GSE23338) and a protein-protein interaction (PPI) analysis were performed to select hub genes.
For the in vitro study, HK-2 cells were exposed to TGF-β1.
The expression of Activin A and STAT3 was assayed, and the effect of Activin A and STAT3 expression on fibrosis was assessed (Collagen I and Fibronectin).
Results: The bioinformatics study revealed TGF-β1 and Activin A as hub genes.
The in vitro study showed that Activin A expression was significantly increased after TGF-β1 incubation.
Blocking Activin A by follistatin attenuated TGF-β1-induced fibrosis.
In addition, Activin A blockade attenuated TGF-β1-induced STAT3 signalling pathway activation and related fibrosis.
More importantly, STAT3 inhibition by S3I-201 alleviated TGF-β1-induced fibrosis.
Conclusion: Activin A promoted cellular fibrotic changes through the STAT3 signalling pathway.
Attenuating Activin A expression to mediate the STAT3 signalling pathway might be a strategy for potent renal fibrosis treatment.
Related Results
179. CHARACTERISATION OF THE IN VITRO FUNCTION OF ACTIVIN AC
179. CHARACTERISATION OF THE IN VITRO FUNCTION OF ACTIVIN AC
Activins are members of the TGF-β superfamily that signal via type II and type I receptor subunits and intracellular Smads1. Activin A stimulates FSH release from the pituitary and...
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract
Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract
Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
Activin-A Impedes the Establishment of CD4+ T Cell Exhaustion and Enhances Anti-Tumor Immunity in the Lung
Activin-A Impedes the Establishment of CD4+ T Cell Exhaustion and Enhances Anti-Tumor Immunity in the Lung
Abstract
Background: Although tumor-infiltrating T cells represent a favorable prognostic marker for cancer patients, the majority of these cells are rendered with an exhau...
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Abstract
Abstract 2849
Poster Board II-825
Histone deacetylase inhibitors (HDACi) are emerging as a potential therapy for Multiple Myel...
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Abstract
STAT3 is involved in the pathogenesis of many malignancies, so we developed an anti-STAT3 VHH (variable region of the heavy chain), SBT-100, that internaliz...
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract
Cancer is often characterized by aberrant gene expression patterns that alter cellular function. Such alterations are commonly caused by the inappropriat...
Activin A and activin receptors in gestational tissue from preeclamptic pregnancies
Activin A and activin receptors in gestational tissue from preeclamptic pregnancies
Abstract
Maternal serum activin A levels are elevated in women with preeclampsia. To explore whether this could be due, at least in part, to increased production ...